Literature DB >> 30739262

Serum ferritin as a biomarker for NAFLD: ready for prime time?

Raj A Shah1, Kris V Kowdley2.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 30739262     DOI： 10.1007/s12072-019-09934-7

Source DB:  PubMed          Journal:  Hepatol Int        ISSN： 1936-0533            Impact factor:   6.047


× No keyword cloud information.
  23 in total

1.  Tolerance of liver biopsy in a tertiary care center: comparison of the percutaneous and the transvenous route in 143 prospectively followed patients.

Authors:  Bogdan Procopet; Christophe Bureau; Sophie Métivier; Janick Selves; Marie Angèle Robic; Camille Christol; Mircea Grigorescu; Jean-Pierre Vinel; Jean-Marie Péron
Journal:  Eur J Gastroenterol Hepatol       Date:  2012-10       Impact factor: 2.566

2.  Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Kris V Kowdley; Patricia Belt; Laura A Wilson; Matthew M Yeh; Brent A Neuschwander-Tetri; Naga Chalasani; Arun J Sanyal; James E Nelson
Journal:  Hepatology       Date:  2011-12-06       Impact factor: 17.425

3.  Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity.

Authors:  Giovanni Musso; Roberto Gambino; Maurizio Cassader; Gianfranco Pagano
Journal:  Ann Med       Date:  2010-11-02       Impact factor: 4.709

4.  Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD).

Authors:  Maria Stepanova; Nila Rafiq; Hala Makhlouf; Ritambhara Agrawal; Ishmeet Kaur; Zahra Younoszai; Arthur McCullough; Zachary Goodman; Zobair M Younossi
Journal:  Dig Dis Sci       Date:  2013-06-18       Impact factor: 3.199

Review 5.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Michael Charlton; Kenneth Cusi; Mary Rinella; Stephen A Harrison; Elizabeth M Brunt; Arun J Sanyal
Journal:  Hepatology       Date:  2017-09-29       Impact factor: 17.425

6.  Diabetes and serum ferritin concentration among U.S. adults.

Authors:  E S Ford; M E Cogswell
Journal:  Diabetes Care       Date:  1999-12       Impact factor: 19.112

7.  Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease.

Authors:  Bryan D Maliken; James E Nelson; Heather M Klintworth; Mary Beauchamp; Matthew M Yeh; Kris V Kowdley
Journal:  Hepatology       Date:  2013-03-14       Impact factor: 17.425

Review 8.  Kupffer cells in non-alcoholic fatty liver disease: the emerging view.

Authors:  György Baffy
Journal:  J Hepatol       Date:  2009-03-31       Impact factor: 25.083

9.  Reference Intervals of Fibrosis Index Based on Four Indicators in Healthy Elderly Chinese.

Authors:  Guo-Ming Zhang; Yong-Jie Xia
Journal:  J Clin Lab Anal       Date:  2016-03-08       Impact factor: 2.352

Review 10.  Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.

Authors:  Per Stål
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742
View more
  7 in total

1.  Therapeutic Effect of Crocin on the NASH Model by Targeting the Fas Receptor Signaling Pathway.

Authors:  Seyyed Ali Mard; Feryal Savari; Anahita Rezaie; Maryam Khosravi
Journal:  Turk J Gastroenterol       Date:  2022-06       Impact factor: 1.555

2.  Efficacy of Hijamat (wet cupping therapy) in Iranian patients with nonalcoholic fatty liver disease: a controlled clinical trial

Authors:  Homayoon Bashiri; Arezoo Bozorgomid; Vahid Shojaeimotlagh
Journal:  Turk J Med Sci       Date:  2020-04-09       Impact factor: 0.973

3.  Predictive Value of Serum Ferritin in Combination with Alanine Aminotransferase and Glucose Levels for Noninvasive Assessment of NAFLD: Fatty Liver in Obesity (FLiO) Study.

Authors:  Cristina Galarregui; Bertha Araceli Marin-Alejandre; Nuria Perez-Diaz-Del-Campo; Irene Cantero; J Ignacio Monreal; Mariana Elorz; Alberto Benito-Boillos; José Ignacio Herrero; Josep A Tur; J Alfredo Martínez; M Angeles Zulet; Itziar Abete
Journal:  Diagnostics (Basel)       Date:  2020-11-08

4.  Elevated serum ferritin level effectively discriminates severity illness and liver injury of coronavirus disease 2019 pneumonia.

Authors:  Peng Cao; Yuanjue Wu; Sanlan Wu; Tingting Wu; Qilin Zhang; Rui Zhang; Zhao Wang; Yu Zhang
Journal:  Biomarkers       Date:  2021-02-10       Impact factor: 2.658

Review 5.  MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis.

Authors:  Nancy de Los Ángeles Segura-Azuara; Carlos Daniel Varela-Chinchilla; Plinio A Trinidad-Calderón
Journal:  Front Med (Lausanne)       Date:  2022-01-13

6.  Reference intervals established using indirect method for serum ferritin assayed on Abbott Architect i2000SR analyzer in Chinese adults.

Authors:  Qing-Ping Wang; Lin-Ying Guo; Zhi-Yong Lu; Jian-Wen Gu
Journal:  J Clin Lab Anal       Date:  2019-11-01       Impact factor: 2.352

7.  Association between Different Animal Protein Sources and Liver Status in Obese Subjects with Non-Alcoholic Fatty Liver Disease: Fatty Liver in Obesity (FLiO) Study.

Authors:  Gregorio Recaredo; Bertha Araceli Marin-Alejandre; Irene Cantero; J Ignacio Monreal; José Ignacio Herrero; Alberto Benito-Boillos; Mariana Elorz; Josep A Tur; J Alfredo Martínez; M Angeles Zulet; Itziar Abete
Journal:  Nutrients       Date:  2019-10-03       Impact factor: 5.717
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.